(Q39148654)

English

Second mitochondria-derived activator of caspase (SMAC) mimetic potentiates tumor susceptibility toward natural killer cell-mediated killing

scientific article published on 26 June 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Second mitochondria-derived activator of caspase (SMAC) mimetic potentiates tumor susceptibility toward natural killer cell-mediated killing (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

1 reference

based on heuristic

inferred from title

6

object named as

Martin Krönke

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

author name string

Kerstin Brinkmann

1

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Andreas Hombach

2

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Jens Michael Seeger

3

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Diana Wagner-Stippich

4

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Daniela Klubertz

5

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Hinrich Abken

7

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Hamid Kashkar

8

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

publication date

26 June 2013

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Leukemia & Lymphoma

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

55

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

645-651

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Hallmarks of Cancer: The Next Generation

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.807925

21 January 2018

Mitochondria as therapeutic targets for cancer chemotherapy

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.807925

21 January 2018

Exploiting mitochondrial apoptosis for the treatment of cancer

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.807925

21 January 2018

The BCL-2 protein family: opposing activities that mediate cell death

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.807925

21 January 2018

Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.807925

21 January 2018

Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.807925

21 January 2018

Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.807925

21 January 2018

The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.807925

21 January 2018

A small molecule Smac mimic potentiates TRAIL- and TNFalpha-mediated cell death

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.807925

21 January 2018

Mimicking the BH3 domain to kill cancer cells

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.807925

21 January 2018

Targeting mitochondria for cancer therapy

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.807925

21 January 2018

A molecular view of cytotoxic T lymphocyte induced killing

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.807925

21 January 2018

Granzymes in cancer and immunity

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.807925

21 January 2018

Enzymatic control of apoptosis

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.807925

21 January 2018

Initiation of apoptosis by granzyme B requires direct cleavage of bid, but not direct granzyme B-mediated caspase activation.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.807925

21 January 2018

Granzyme B-induced apoptosis requires both direct caspase activation and relief of caspase inhibition

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.807925

21 January 2018

Caspase activation by granzyme B is indirect, and caspase autoprocessing requires the release of proapoptotic mitochondrial factors.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.807925

21 January 2018

Resistance of cancers to immunologic cytotoxicity and adoptive immunotherapy via X-linked inhibitor of apoptosis protein expression and coexisting defects in mitochondrial death signaling

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.807925

21 January 2018

The proteasome inhibitor bortezomib sensitizes melanoma cells toward adoptive CTL attack

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.807925

21 January 2018

Defective Bax activation in Hodgkin B-cell lines confers resistance to staurosporine-induced apoptosis

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.807925

21 January 2018

IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.807925

21 January 2018

Acid sphingomyelinase is indispensable for UV light-induced Bax conformational change at the mitochondrial membrane.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.807925

21 January 2018

Ubiquitin C-terminal hydrolase-L1 potentiates cancer chemosensitivity by stabilizing NOXA.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.807925

21 January 2018

cIAP2 is highly expressed in Hodgkin-Reed-Sternberg cells and inhibits apoptosis by interfering with constitutively active caspase-3.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.807925

21 January 2018

XIAP-mediated caspase inhibition in Hodgkin's lymphoma-derived B cells

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.807925

21 January 2018

Expression of inhibitor of apoptosis proteins in B-cell non-Hodgkin and Hodgkin lymphomas

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.807925

21 January 2018

Cultivated H-RS cells are resistant to CD95L-mediated apoptosis despite expression of wild-type CD95.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.807925

21 January 2018

The molecular pathogenesis of Hodgkin lymphoma.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.807925

21 January 2018

Pretreatment mitochondrial priming correlates with clinical response to cytotoxic chemotherapy

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.807925

21 January 2018

XIAP discriminates between type I and type II FAS-induced apoptosis

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.807925

21 January 2018

Smac/DIABLO release from mitochondria and XIAP inhibition are essential to limit clonogenicity of Type I tumor cells after TRAIL receptor stimulation

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.807925

21 January 2018

X-linked Inhibitor of Apoptosis: A Chemoresistance Factor or a Hollow Promise

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.807925

21 January 2018

Diagnosing and exploiting cancer's addiction to blocks in apoptosis

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.807925

21 January 2018

Smac mimetics increase cancer cell response to chemotherapeutics in a TNF-α-dependent manner

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.807925

21 January 2018

Smac mimetic increases chemotherapy response and improves survival in mice with pancreatic cancer

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.807925

21 January 2018

IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.807925

21 January 2018

Elevated XIAP expression alone does not confer chemoresistance

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.807925

21 January 2018

TNF-Induced Target Cell Killing by CTL Activated through Cross-Presentation

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.807925

21 January 2018

Identifiers

10.3109/10428194.2013.807925

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39148654&oldid=1809626722"